Generare
PrivateLast Round
Series A
Apr 2, 2026
Total Funding Raised
$28.4M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Generare is a biotechnology company that has developed a data-driven discovery platform to identify novel bioactive molecules from microbes for applications in medicine and other industries.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Generare Comparables
Compare Generare with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hexagon Bio | 82% | |
| Empress Therapeutics | 78% | |
| Biomia | 77% | |
Generare Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 2, 2026 | ||||
| Seed | Oct 8, 2024 |
Generare Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Saras Capital | Seed |
| Alven | Series A |
| SynBioVen | Seed |
| Daphni | Series A |
| Galion.exe | Series A, Seed |
| VIVES Partners | Series A, Seed |
| Better Angle | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 2, 2026
$23M round completed.
- Oct 8, 2024
$5.5M raised in Seed round.
Generare Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Generare's valuation, stock price, and market status.